Fubuki XF Long Sheath guide catheter use in neuroendovascular procedures: Institutional experience in 60 cases
CONCLUSION: We used Fubuki XF to safely and effectively deliver a variety of compatible neuroendovascular devices. Fubuki XF was stable in all cases and locations, and there were no device-related complications or dissections.PMID:38592015 | DOI:10.1177/15910199241245601 (Source: Interventional Neuroradiology)
Source: Interventional Neuroradiology - April 9, 2024 Category: Radiology Authors: Hamzah M Saei Samantha E Miller Holly M Pope Ameer E Hassan Source Type: research
Prognostic impact of carotid plaque imaging using total plaque area added to SCORE2 in middle-aged subjects: the ARteris Cardiovascular Outcome (ARCO) cohort study
CONCLUSIONS: Integration of TPA post-test risk into SCORE2 adds prognostic information, supporting the use of carotid ultrasound when assessing ASCVD risk in subjects aged 40-65 years.PMID:38579303 | DOI:10.57187/s.3735 (Source: Atherosclerosis)
Source: Atherosclerosis - April 5, 2024 Category: Cardiology Authors: Michel Romanens Ansgar Adams Michel Wenger Walter Warmuth Isabella Sudano Source Type: research
Prognostic impact of carotid plaque imaging using total plaque area added to SCORE2 in middle-aged subjects: the ARteris Cardiovascular Outcome (ARCO) cohort study
CONCLUSIONS: Integration of TPA post-test risk into SCORE2 adds prognostic information, supporting the use of carotid ultrasound when assessing ASCVD risk in subjects aged 40-65 years.PMID:38579303 | DOI:10.57187/s.3735 (Source: Swiss Medical Weekly)
Source: Swiss Medical Weekly - April 5, 2024 Category: General Medicine Authors: Michel Romanens Ansgar Adams Michel Wenger Walter Warmuth Isabella Sudano Source Type: research
Prognostic impact of carotid plaque imaging using total plaque area added to SCORE2 in middle-aged subjects: the ARteris Cardiovascular Outcome (ARCO) cohort study
CONCLUSIONS: Integration of TPA post-test risk into SCORE2 adds prognostic information, supporting the use of carotid ultrasound when assessing ASCVD risk in subjects aged 40-65 years.PMID:38579303 | DOI:10.57187/s.3735 (Source: Swiss Medical Weekly)
Source: Swiss Medical Weekly - April 5, 2024 Category: General Medicine Authors: Michel Romanens Ansgar Adams Michel Wenger Walter Warmuth Isabella Sudano Source Type: research
Prognostic impact of carotid plaque imaging using total plaque area added to SCORE2 in middle-aged subjects: the ARteris Cardiovascular Outcome (ARCO) cohort study
CONCLUSIONS: Integration of TPA post-test risk into SCORE2 adds prognostic information, supporting the use of carotid ultrasound when assessing ASCVD risk in subjects aged 40-65 years.PMID:38579303 | DOI:10.57187/s.3735 (Source: Swiss Medical Weekly)
Source: Swiss Medical Weekly - April 5, 2024 Category: General Medicine Authors: Michel Romanens Ansgar Adams Michel Wenger Walter Warmuth Isabella Sudano Source Type: research
Fibromuscular dysplasia of the renal arteries: what do we know in 2024?
Nephrol Ther. 2024 Apr 4;20(2):1-9. doi: 10.1684/ndt.2024.70. Online ahead of print.ABSTRACTFibromuscular dysplasia (FMD) is a rare nonatherosclerotic, noninflammatory vascular disease affecting mostly renal and carotid arteries and is the second most frequent cause of renal artery stenosis. The symptomatology is dominated by arterial hypertension due to the frequent involvement of the renal arteries and depends on the location of the lesions. Most of the cases are middle-aged women of Caucasian origin. There are two subtypes based on angiographic aspect: multifocal FMD (80% of the cases) and focal FMD (rarer with a more b...
Source: Nephrologie and Therapeutique - April 3, 2024 Category: Urology & Nephrology Authors: Corentin Tournebize Sandrine Lemoine Caroline Pelletier Source Type: research
Fibromuscular dysplasia of the renal arteries: what do we know in 2024?
Nephrol Ther. 2024 Apr 4;20(2):1-9. doi: 10.1684/ndt.2024.70. Online ahead of print.ABSTRACTFibromuscular dysplasia (FMD) is a rare nonatherosclerotic, noninflammatory vascular disease affecting mostly renal and carotid arteries and is the second most frequent cause of renal artery stenosis. The symptomatology is dominated by arterial hypertension due to the frequent involvement of the renal arteries and depends on the location of the lesions. Most of the cases are middle-aged women of Caucasian origin. There are two subtypes based on angiographic aspect: multifocal FMD (80% of the cases) and focal FMD (rarer with a more b...
Source: Nephrologie and Therapeutique - April 3, 2024 Category: Urology & Nephrology Authors: Corentin Tournebize Sandrine Lemoine Caroline Pelletier Source Type: research
Fibromuscular dysplasia of the renal arteries: what do we know in 2024?
Nephrol Ther. 2024 Apr 4;20(2):1-9. doi: 10.1684/ndt.2024.70. Online ahead of print.ABSTRACTFibromuscular dysplasia (FMD) is a rare nonatherosclerotic, noninflammatory vascular disease affecting mostly renal and carotid arteries and is the second most frequent cause of renal artery stenosis. The symptomatology is dominated by arterial hypertension due to the frequent involvement of the renal arteries and depends on the location of the lesions. Most of the cases are middle-aged women of Caucasian origin. There are two subtypes based on angiographic aspect: multifocal FMD (80% of the cases) and focal FMD (rarer with a more b...
Source: Nephrologie and Therapeutique - April 3, 2024 Category: Urology & Nephrology Authors: Corentin Tournebize Sandrine Lemoine Caroline Pelletier Source Type: research
Fibromuscular dysplasia of the renal arteries: what do we know in 2024?
Nephrol Ther. 2024 Apr 4;20(2):1-9. doi: 10.1684/ndt.2024.70. Online ahead of print.ABSTRACTFibromuscular dysplasia (FMD) is a rare nonatherosclerotic, noninflammatory vascular disease affecting mostly renal and carotid arteries and is the second most frequent cause of renal artery stenosis. The symptomatology is dominated by arterial hypertension due to the frequent involvement of the renal arteries and depends on the location of the lesions. Most of the cases are middle-aged women of Caucasian origin. There are two subtypes based on angiographic aspect: multifocal FMD (80% of the cases) and focal FMD (rarer with a more b...
Source: Nephrologie and Therapeutique - April 3, 2024 Category: Urology & Nephrology Authors: Corentin Tournebize Sandrine Lemoine Caroline Pelletier Source Type: research
Fibromuscular dysplasia of the renal arteries: what do we know in 2024?
Nephrol Ther. 2024 Apr 4;20(2):1-9. doi: 10.1684/ndt.2024.70. Online ahead of print.ABSTRACTFibromuscular dysplasia (FMD) is a rare nonatherosclerotic, noninflammatory vascular disease affecting mostly renal and carotid arteries and is the second most frequent cause of renal artery stenosis. The symptomatology is dominated by arterial hypertension due to the frequent involvement of the renal arteries and depends on the location of the lesions. Most of the cases are middle-aged women of Caucasian origin. There are two subtypes based on angiographic aspect: multifocal FMD (80% of the cases) and focal FMD (rarer with a more b...
Source: Nephrologie and Therapeutique - April 3, 2024 Category: Urology & Nephrology Authors: Corentin Tournebize Sandrine Lemoine Caroline Pelletier Source Type: research
Safety and efficacy of early carotid artery stenting in patients with symptomatic stenosis
CONCLUSION: Early CAS within the high-risk window post-symptom onset is a viable secondary stroke prevention strategy in patients with symptomatic carotid artery stenosis. The procedure rate of complication is acceptable, with a low recurrence of stroke. However, further careful selection of patients for this procedural strategy is crucial to optimize outcomes.PMID:38515363 | DOI:10.1177/15910199241239204 (Source: Interventional Neuroradiology)
Source: Interventional Neuroradiology - March 22, 2024 Category: Radiology Authors: Isabel Rodr íguez Laura Ludovica Gramegna Manuel Requena Michele Rizzuti Iker Elosua Jordi Mayol Marta Oliv é-Gadea Francesco Diana Marc Rodrigo-Gisbert Mari án Muchada Eila Rivera Álvaro García-Tornel Federica Rizzo Marta De Dios David Rodr íguez-L Source Type: research
Safety and efficacy of early carotid artery stenting in patients with symptomatic stenosis
CONCLUSION: Early CAS within the high-risk window post-symptom onset is a viable secondary stroke prevention strategy in patients with symptomatic carotid artery stenosis. The procedure rate of complication is acceptable, with a low recurrence of stroke. However, further careful selection of patients for this procedural strategy is crucial to optimize outcomes.PMID:38515363 | DOI:10.1177/15910199241239204 (Source: Atherosclerosis)
Source: Atherosclerosis - March 22, 2024 Category: Cardiology Authors: Isabel Rodr íguez Laura Ludovica Gramegna Manuel Requena Michele Rizzuti Iker Elosua Jordi Mayol Marta Oliv é-Gadea Francesco Diana Marc Rodrigo-Gisbert Mari án Muchada Eila Rivera Álvaro García-Tornel Federica Rizzo Marta De Dios David Rodr íguez-L Source Type: research
Safety and efficacy of early carotid artery stenting in patients with symptomatic stenosis
CONCLUSION: Early CAS within the high-risk window post-symptom onset is a viable secondary stroke prevention strategy in patients with symptomatic carotid artery stenosis. The procedure rate of complication is acceptable, with a low recurrence of stroke. However, further careful selection of patients for this procedural strategy is crucial to optimize outcomes.PMID:38515363 | DOI:10.1177/15910199241239204 (Source: Interventional Neuroradiology)
Source: Interventional Neuroradiology - March 22, 2024 Category: Radiology Authors: Isabel Rodr íguez Laura Ludovica Gramegna Manuel Requena Michele Rizzuti Iker Elosua Jordi Mayol Marta Oliv é-Gadea Francesco Diana Marc Rodrigo-Gisbert Mari án Muchada Eila Rivera Álvaro García-Tornel Federica Rizzo Marta De Dios David Rodr íguez-L Source Type: research
